Canton Strategic Holdings CNTN
NASDAQ CNTN
$2.28 +0.03 (+1.33%)
As of: Sep 4, 2026 · 3:59 PM EDT

Canton Strategic Holdings (CNTN) Free Cash Flow (2021 - 2026)

Canton Strategic Holdings' (CNTN) quarterly Free Cash Flow came in at -$7.6 million in Q1 2026, down 183.94% YoY from $9.1 million in Q1 2025, and up 26.88% on a QoQ basis from -$10.4 million in Q4 2025.

Analysis

Canton Strategic Holdings (CNTN) Free Cash Flow (2021 - 2026) Analysis & Trends

Canton Strategic Holdings (CNTN) has 6 years of Free Cash Flow data on file, last reported at -$7.6 million in Q1 2026.

  • Quarterly Free Cash Flow fell 183.94% year-over-year to -$7.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$21.1 million (down 95.79% YoY) and the FY2025 annual result came in at -$16.1 million, down 47.97% from the prior year.
  • Free Cash Flow advanced to -$7.6 million in Q1 2026, from -$10.4 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of -$892676.0 in Q4 2022 to a low of -$10.4 million in Q4 2025.
  • A 5-year average of -$2.9 million and a median of -$2.2 million in 2024 frame the typical range for Free Cash Flow.
  • Annual changes were most pronounced in 2022 — Free Cash Flow plunged 11530.96% — and 2025, when it soared 47.57%.
  • Tracing CNTN's Free Cash Flow over 5 years: stood at -$892676.0 in 2022, then slumped by 58.56% to -$1.4 million in 2023, then plunged by 114.19% to -$3.0 million in 2024, then slumped by 244.42% to -$10.4 million in 2025, then increased by 26.88% to -$7.6 million in 2026.
  • The last three Free Cash Flow figures came in at -$7.6 million (Q1 2026), -$10.4 million (Q4 2025), and -$1.9 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.01 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 572.80 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -563.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -389.61 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 437.80 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 292.04 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 477.44 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -95.09 Mn
10 Canton Strategic Holdings 493.37 Mn 493.37 Mn - -7.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -7.00 Mn
Mar 31, 2026 -62.46 Mn
Dec 31, 2025 -10.43 Mn
Sep 30, 2025 -1.87 Mn
Jun 30, 2025 -1.14 Mn
Mar 31, 2025 -2.69 Mn
Dec 31, 2024 -3.03 Mn
Sep 30, 2024 -2.86 Mn
Jun 30, 2024 -2.18 Mn
Mar 31, 2024 -2.83 Mn
Dec 31, 2023 -1.42 Mn
Sep 30, 2023 -908,966.00
Jun 30, 2023 -1.51 Mn
Mar 31, 2023 -3.46 Mn
Dec 31, 2022 -892,676.00
Sep 30, 2022 -1.55 Mn
Jun 30, 2022 -1.39 Mn
Mar 31, 2022 -2.73 Mn
Dec 31, 2021 -7,675.00
Sep 30, 2021 -316,776.00